Lake Street Advisors Group LLC acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the 1st quarter, Holdings Channel.com reports. The fund acquired 8,583 shares of the exchange traded fund’s stock, valued at approximately $814,000.
A number of other hedge funds have also recently modified their holdings of XBI. ICA Group Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $27,000. Scarborough Advisors LLC purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter worth about $32,000. BOCHK Asset Management Ltd purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter worth about $36,000. Tennessee Valley Asset Management Partners bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $44,000. Finally, Wetzel Investment Advisors Inc. purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $45,000.
SPDR S&P Biotech ETF Stock Performance
Shares of XBI traded up $2.93 during mid-day trading on Thursday, reaching $101.97. The company had a trading volume of 4,958,738 shares, compared to its average volume of 10,347,839. The company has a market capitalization of $7.77 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The firm has a 50-day moving average price of $93.10 and a 200 day moving average price of $91.90. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
- Insider Trading – What You Need to Know
- Qualcomm Stock Could Be On The Verge of an Impressive Rally
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.